Filing Details

Accession Number:
0001209191-19-005422
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-25 18:24:39
Reporting Period:
2019-01-23
Accepted Time:
2019-01-25 18:24:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1446847 Ironwood Pharmaceuticals Inc IRWD Pharmaceutical Preparations (2834) 043404176
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478485 M Peter Hecht C/O Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge MA 02142
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2019-01-23 30,000 $4.89 4,726,917 No 4 M Direct
Class A Common Stock Disposition 2019-01-23 30,000 $12.66 4,696,917 No 4 S Direct
Class A Common Stock Acquisiton 2019-01-24 30,000 $4.89 4,726,917 No 4 M Direct
Class A Common Stock Disposition 2019-01-24 30,000 $12.70 4,696,917 No 4 S Direct
Class A Common Stock Acquisiton 2019-01-25 29,551 $4.89 4,726,468 No 4 M Direct
Class A Common Stock Disposition 2019-01-25 29,551 $12.23 4,696,917 No 4 S Direct
Class A Common Stock Acquisiton 2019-01-25 20,449 $4.89 4,717,366 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2019-01-23 30,000 $0.00 30,000 $4.89
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2019-01-24 30,000 $0.00 30,000 $4.89
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2019-01-25 29,551 $0.00 29,551 $4.89
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2019-01-25 20,449 $0.00 20,449 $4.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
80,000 2019-02-11 No 4 M Direct
50,000 2019-02-11 No 4 M Direct
20,449 2019-02-11 No 4 M Direct
0 2019-02-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 4,850 Indirect The 2000 Trust for Alexis Mae Hecht
Class A Common Stock 4,850 Indirect The 2000 Trust for Malcolm Paul Hecht
Class A Common Stock 4,850 Indirect The 2000 Trust for Zoe Niovi Hecht
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and to cover the tax liabilities arising out of the exercises of stock options of the issuer reported on this form, as well as prior exercises in which the reporting person paid the exercise price and held the underlying shares at the time of exercise.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.40 to $12.91, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $13.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.
  6. The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2013.